Peter Yu
About Peter Yu
Peter Yu is the Director of Manufacture Science & Technology at Bristol-Myers Squibb in Shanghai Suburb, China, with over 25 years of experience in pharmaceutical manufacturing and a strong academic background in plant biochemistry and cellular and molecular biology.
Professional Background at Bristol-Myers Squibb
Peter Yu currently holds the position of Director of Manufacture Science & Technology at Bristol-Myers Squibb in Shanghai Suburb, China. He began his career at the same company as a Process Engineer from 1997 to 1998. After gaining valuable experience at Shanghai Pharma, he rejoined Bristol-Myers Squibb, where he has now been contributing for over 25 years. Peter Yu has played a crucial role in advancing manufacturing technologies and has a deep understanding of the Chinese pharmaceutical manufacturing landscape.
Experience in Upstream Process Engineering
Before rejoining Bristol-Myers Squibb, Peter Yu worked as an Upstream Process Engineer at Shanghai Pharma's Bio Plant, Sunve Company from 1995 to 1997. His work focused on upstream process engineering, providing him with extensive experience in this critical area of pharmaceutical manufacturing. This background has informed his later roles and contributed to his effectiveness as Director of Manufacture Science & Technology.
Academic Qualifications in Biological Sciences
Peter Yu has a solid academic foundation in biological sciences. He earned his Bachelor's Degree in Cell/Cellular and Molecular Biology from Lanzhou University, where he studied from 1988 to 1992. He then undertook a Master's basic course in Biology, General, at the University of Chinese Academy of Sciences from 1992 to 1993. His academic journey continued with a Master's Degree in Plant Biochemistry from the Kunming Institute of Botany, Chinese Academy of Sciences, which he completed from 1993 to 1995.
Role in Development and Implementation of Manufacturing Technologies
Throughout his career at Bristol-Myers Squibb, Peter Yu has been instrumental in the development and implementation of manufacturing technologies. His expertise has been vital in improving the efficiency and effectiveness of manufacturing processes, particularly within the Chinese market. His work has had a significant impact on the company's operations in China, showcasing his deep understanding of pharmaceutical manufacturing technologies.